MK-4827 (Niraparib)
10mM in DMSO
- Product Code: 204527
CAS:
1038915-60-4
| Molecular Weight: | 320.39 g./mol | Molecular Formula: | C₁₉H₂₀N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in the treatment of ovarian, fallopian tube, and peritoneal cancers, especially in patients who have recurrent disease and are in complete or partial response to platinum-based chemotherapy. It is also approved for use in certain patients with breast cancer who have inherited BRCA mutations. As a PARP inhibitor, it works by blocking enzymes involved in DNA repair, leading to cancer cell death. The drug is taken orally and allows for targeted therapy with improved progression-free survival in clinical settings.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿5,530.00 |
+
-
|
MK-4827 (Niraparib)
Used primarily in the treatment of ovarian, fallopian tube, and peritoneal cancers, especially in patients who have recurrent disease and are in complete or partial response to platinum-based chemotherapy. It is also approved for use in certain patients with breast cancer who have inherited BRCA mutations. As a PARP inhibitor, it works by blocking enzymes involved in DNA repair, leading to cancer cell death. The drug is taken orally and allows for targeted therapy with improved progression-free survival in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :